Impact of geriatric comorbidity and polypharmacy on cholinesterase inhibitors prescribing in dementia

BACKGROUND: Although most guidelines recommend the use of cholinesterase inhibitors (ChEIs) for mild to moderate Alzheimer's Disease, only a small proportion of affected patients receive these drugs. We aimed to study if geriatric comorbidity and polypharmacy influence the prescription of ChEIs...

Полное описание

Сохранить в:
Библиографические подробности
Главные авторы: Hoffmann, Falk, van den Bussche, Hendrik, Wiese, Birgitt, Schön, Gerhard, Koller, Daniela, Eisele, Marion, Glaeske, Gerd, Scherer, Martin, Kaduszkiewicz, Hanna
Формат: Artigo
Язык:Inglês
Опубликовано: BioMed Central 2011
Предметы:
Research Article
Online-ссылка:https://ncbi.nlm.nih.gov/pmc/articles/PMC3262154/
https://ncbi.nlm.nih.gov/pubmed/22145796
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1471-244X-11-190
Метки: Добавить метку
Нет меток, Требуется 1-ая метка записи!

Схожие документы